Richard McHale - ResMed Insider

RMD -- USA Stock  

USD 108.97  0.15  0.14%

President ? Respiratory Care
Mr. Richard McHale is President Respiratory Care of the Company. He previously served as the companys chief human resources officer, beginning in November 2013, and joined ResMed in 2011 as director of its United Kingdom business team. Mr. McHale has 25 years experience in the life sciences sector, working primarily in commercial roles within pharmaceutical, biotechnology and medical technology companies. Prior to joining ResMed, he was managing director of UCB Pharmas United Kingdom and Ireland business units. He also served as chair of the European Medicines Group and a member of the Board of Management for the Association of British Pharmaceutical Industry
Age: 52  President Since 2017      
858-836-5000  http://www.resmed.com
McHale holds a master?s degree in coaching psychology from the Metanoia Institute in London.

Richard McHale Latest Insider Activity

Richard McHale over three months ago via Macroaxis 
Sale by Richard McHale of 2000 shares of ResMed

Management Efficiency

The company has Return on Asset of 9.58 % which means that on every $100 spent on asset it made $9.58 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.68 % implying that it generated $15.68 on every 100 dollars invested.
The company has 810 M in debt with debt to equity (D/E) ratio of 39.1 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 3.41 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Mary LadoneHill Rom Holdings
2018
Michael MurphyHill Rom Holdings
2012
Linda TharbyBecton Dickinson and Company
2016
Cristiano FranziBaxter International
2017
Andrew FryeBaxter International
2017
Carlos AlonsoHill Rom Holdings
2015
Holly SheffieldThe Cooper Companies
2018
Jeffrey ShermanBecton Dickinson and Company
2006
James MachekEndologix
2015
Charles LoveEndologix
2012
Deborah RasinHill Rom Holdings
2016
Daniel McBrideThe Cooper Companies
2014
Dirk EhlersHill Rom Holdings
2016
Seth YellinCantel Medical Corp
2016
Carlos MarumHill Rom Holdings
2015
Francisco VegaHill Rom Holdings
2017
Thomas PolenBecton Dickinson and Company
2017
Ludwig HantsonBaxter International
2010
Steven AnayaCantel Medical Corp
2014
Russ AngoldEkso Bionics Holdings
2014
Patrick KaltenbachBecton Dickinson and Company
2018

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on New York Stock Exchange. It employs 6000 people.ResMed (RMD) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 6,000 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.

ResMed Leadership Team

John Wareham, Director, MBA
Ronald Taylor, Director
Rob Douglas, President
Christopher Roberts, Director, MBA
Gary Pace, Director, Ph.D
Chris Roberts, Director, MBA
Robert Douglas, COO
Agnes Lee, Director
Carol Burt, Director
Rich Sulpizio, Director
Peter Farrell, Chairman, Ph.D
Jim Hollingshead, President, Ph.D
Brett Sandercock, CFO
Ron Taylor, Director
Don Darkin, President
Jack Wareham, Director
Anne Reiser, President
Karen Drexler, Director
Raj Sodhi, President, MBA
David Pendarvis, Executive
Richard Sulpizio, Director
Michael Farrell, CEO, MBA
Richard McHale, President
Donald Darkin, President

Stock Performance Indicators

Current Sentiment - RMD

ResMed Investor Sentiment
Greater number of Macroaxis users are at this time bullish on ResMed. What is your perspective on investing in ResMed? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
DD   
Purchased over 100 shares of
few hours ago
Traded for 25.35
S   
Purchased over 500 shares of
few hours ago
Traded for 5.66
GOOG   
Purchased few shares of
few hours ago
Traded for 1188.8199
GM   
Purchased over 70 shares of
few hours ago
Traded for 39.36
GOOG   
Purchased few shares of
few hours ago
Traded for 1188.8199
Additionally take a look at Your Equity Center. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.